Davidson Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
277,201
-15,902
-5% -$913K 0.65% 59
2026
Q1
$17.8M Sell
293,103
-6,411
-2% -$374K 0.77% 51
2025
Q4
$16.2M Sell
299,514
-3,839
-1% -$185K 0.67% 61
2025
Q3
$13.7M Buy
303,353
+12,492
+4% +$583K 0.58% 69
2025
Q2
$13.5M Sell
290,861
-9,505
-3% -$467K 0.61% 69
2025
Q1
$18.3M Buy
300,366
+9,045
+3% +$527K 0.9% 42
2024
Q4
$16.5M Buy
291,321
+3,784
+1% +$211K 0.8% 52
2024
Q3
$14.9M Buy
287,537
+12,995
+5% +$610K 0.72% 64
2024
Q2
$11.4M Buy
274,542
+4,631
+2% +$207K 0.59% 74
2024
Q1
$14.6M Buy
269,911
+18,401
+7% +$937K 0.76% 61
2023
Q4
$12.9M Sell
251,510
-6,435
-2% -$338K 0.74% 63
2023
Q3
$15M Buy
257,945
+5,965
+2% +$365K 0.95% 49
2023
Q2
$16.1M Buy
251,980
+41,270
+20% +$2.77M 1.02% 41
2023
Q1
$14.6M Buy
210,710
+20,614
+11% +$1.45M 0.96% 47
2022
Q4
$13.7M Buy
190,096
+3,681
+2% +$278K 1.06% 42
2022
Q3
$13.3M Buy
186,415
+7,568
+4% +$549K 1.11% 35
2022
Q2
$13.8M Buy
178,847
+1,831
+1% +$139K 1.17% 34
2022
Q1
$12.9M Buy
177,016
+3,125
+2% +$210K 0.94% 54
2021
Q4
$10.8M Sell
173,891
-3,370
-2% -$198K 0.77% 56
2021
Q3
$10.5M Buy
177,261
+6,299
+4% +$415K 0.82% 59
2021
Q2
$11.4M Sell
170,962
-2,101
-1% -$137K 0.91% 51
2021
Q1
$10.9M Buy
173,063
+5,876
+4% +$366K 0.93% 55
2020
Q4
$10.4M Sell
167,187
-1,805
-1% -$111K 0.96% 55
2020
Q3
$10.2M Sell
168,992
-347
-0.2% -$20.9K 1.08% 35
2020
Q2
$9.96M Buy
169,339
+39,910
+31% +$2.39M 1.1% 29
2020
Q1
$7.21M Sell
129,429
-5,308
-4% -$324K 0.93% 49
2019
Q4
$8.65M Buy
+134,737
New +$7.72M 0.84% 53
2017
Q3
Sell
-2,240
Closed -$124K 114
2017
Q2
$124K Hold
2,240
0.02% 106
2017
Q1
$121K Buy
2,240
+390
+21% +$21.4K 0.02% 112
2016
Q4
$107K Buy
1,850
+150
+9% +$8.2K 0.02% 118
2016
Q3
$91K Buy
1,700
+400
+31% +$25.7K 0.01% 118
2016
Q2
$95K Hold
1,300
0.02% 118
2016
Q1
$83K Buy
1,300
+1,000
+333% +$63.1K 0.01% 152
2015
Q4
$20K Hold
300
﹤0.01% 186
2015
Q3
$17K Buy
+300
New +$19K ﹤0.01% 180
2015
Q2
Sell
-1,000
Closed -$64K 203
2015
Q1
$64K Sell
1,000
-500
-33% -$31.3K 0.01% 152
2014
Q4
$88K Sell
1,500
-2,000
-57% -$113K 0.01% 139
2014
Q3
$168K Buy
3,500
+2,000
+133% +$99.9K 0.01% 147
2014
Q2
$72K Hold
1,500
0.01% 148
2014
Q1
$77K Hold
1,500
0.01% 140
2013
Q4
$79K Sell
1,500
-500
-25% -$25.5K 0.01% 134
2013
Q3
$92K Hold
2,000
0.01% 126
2013
Q2
$89K Buy
+2,000
New +$86.8K 0.01% 128

Other funds holding BMY

Davidson Investment Advisors's BMY Position: Q2 2026 in Review

Davidson Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.4% in Q2 2026, selling an estimated $913K and leaving 277,201 shares worth $16M. The position accounts for 0.65% of the portfolio, ranked #59.

Davidson Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. The position peaked at $18.3M in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Davidson Investment Advisors held 277,201 shares of Bristol-Myers Squibb worth $16M as of Q2 2026.
  • Davidson Investment Advisors sold 15,902 Bristol-Myers Squibb shares in Q2 2026, an estimated $913K.
  • Bristol-Myers Squibb made up 0.65% of Davidson Investment Advisors's portfolio in Q2 2026, its #59 holding.
  • Davidson Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
  • Davidson Investment Advisors's Bristol-Myers Squibb position peaked at $18.3M in Q1 2025.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.